OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

GALNT14 Regulates Ferroptosis and Apoptosis of Ovarian Cancer Through the EGFR/mTOR Pathway
Huawen Li, Mubiao Liu, Xue Jiang, et al.
Future Oncology (2021) Vol. 18, Iss. 2, pp. 149-161
Open Access | Times Cited: 43

Showing 1-25 of 43 citing articles:

Overcoming cancer chemotherapy resistance by the induction of ferroptosis
Yumin Wang, Xiaorui Wu, Ren Zhao, et al.
Drug Resistance Updates (2022) Vol. 66, pp. 100916-100916
Closed Access | Times Cited: 158

Targeting epigenetic and posttranslational modifications regulating ferroptosis for the treatment of diseases
Yumin Wang, Jing Hu, Shuang Wu, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 72

Ferroptosis and Its Role in Chronic Diseases
Wenli Hu, Kehong Liang, Hong Zhu, et al.
Cells (2022) Vol. 11, Iss. 13, pp. 2040-2040
Open Access | Times Cited: 62

Ferroptosis, necroptosis, and pyroptosis in the occurrence and development of ovarian cancer
Chunmei Zhang, Ning Liu
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 54

Targeting Ferroptosis Pathway to Combat Therapy Resistance and Metastasis of Cancer
Xuan Liu, Yiqian Zhang, Xuyi Wu, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 43

Targeting ferroptosis in ovarian cancer: Novel strategies to overcome chemotherapy resistance
Celine Kapper, Peter Oppelt, Barbara Arbeithuber, et al.
Life Sciences (2024) Vol. 349, pp. 122720-122720
Open Access | Times Cited: 8

Inhibiting SCD expression by IGF1R during lorlatinib therapy sensitizes melanoma to ferroptosis
Furong Zeng, Lin Ye, Qian Zhou, et al.
Redox Biology (2023) Vol. 61, pp. 102653-102653
Open Access | Times Cited: 21

GALNTs: master regulators of metastasis-associated epithelial-mesenchymal transition (EMT)?
Ellie-May Beaman, David R. F. Carter, Susan A. Brooks
Glycobiology (2022) Vol. 32, Iss. 7, pp. 556-579
Open Access | Times Cited: 25

mTORC1 beyond anabolic metabolism: Regulation of cell death
Jiajun Zhu, Hua Wang, Xuejun Jiang
The Journal of Cell Biology (2022) Vol. 221, Iss. 12
Open Access | Times Cited: 23

Relationship of mTORC1 and ferroptosis in tumors
Huilin Liao, Yueqing Wang, Lili Zou, et al.
Discover Oncology (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 5

Ferroptosis and pyroptosis are connected through autophagy: a new perspective of overcoming drug resistance
Peng Zhao, Shuangshuang Yin, Yuling Qiu, et al.
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access

The Antiglioma Potential of Plant Lectins: Molecular Targets, Mechanisms, and Future Directions
Rodrigo Bainy Leal, Vanir Reis Pinto‐Junior, Messias Vital Oliveira, et al.
Neuroglia (2025) Vol. 6, Iss. 1, pp. 5-5
Open Access

Expression of 9-O-Acetylated Sialic Acid in HPV+ Oral Squamous Cell Carcinoma Cells
Hugo Sánchez-Martínez, Victoria Jiménez-Castillo, Daniela Illescas-Barbosa, et al.
Life (2025) Vol. 15, Iss. 4, pp. 663-663
Open Access

Current progress of ferroptosis study in ovarian cancer
Zhuomin Tan, Hui Huang, Wenyan Sun, et al.
Frontiers in Molecular Biosciences (2022) Vol. 9
Open Access | Times Cited: 17

Relationships of ferroptosis-related genes with the pathogenesis in polycystic ovary syndrome
Shuang Lin, Xin Jin, Gu He, et al.
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 9

Chrysophanol induces apoptosis and ferroptosis of gastric cancer cells by targeted regulation of mTOR
Sujuan Xi, Wei Ding, Danping Weng, et al.
Chemical Biology & Drug Design (2024) Vol. 103, Iss. 1
Closed Access | Times Cited: 3

Ferroptosis: insight into the treatment of hepatocellular carcinoma
Chuanjie Liao, Youwu He, Xingju Luo, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 3

Emerging roles of GALNT5 on promoting EGFR activation in cholangiocarcinoma: a mechanistic insight.
Marutpong Detarya, Worachart Lert-itthiporn, Panupong Mahalapbutr, et al.
PubMed (2022) Vol. 12, Iss. 9, pp. 4140-4159
Closed Access | Times Cited: 14

Ferroptosis in epithelial ovarian cancer: a burgeoning target with extraordinary therapeutic potential
Danhua Ruan, Jirui Wen, Fei Fang, et al.
Cell Death Discovery (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 6

The recent advancements of ferroptosis in the diagnosis, treatment and prognosis of ovarian cancer
Biqing Chen, Liping Zhao, Rulin Yang, et al.
Frontiers in Genetics (2023) Vol. 14
Open Access | Times Cited: 5

Stromal-epithelial interaction induces GALNT14 in prostate carcinoma cells
Elena Dilâra Czyrnik, Marc Wiesehöfer, Jaroslaw Thomas Dankert, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 4

Page 1 - Next Page

Scroll to top